In fact, FGF23 has been shown to be associated with markers of insulin resistance, dyslipidemia and obesity, suggesting the FGF23 could be a cardiometabolic risk factor connecting obesity and higher cardiovascular complications [29]. The gene discussed is FGF23; the disease is obesity due to melanocortin 4 receptor deficiency.